QualityStocksNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Provides Recent Activities Update

HTC Extraction Systems (TSX.V: HTC), a hemp-biomass processing entity, today announced that it has closed its bought deal private placement resulting in gross proceeds of $10 million. In addition, the company reported the completion of its 19,000-square-foot facility that will house quality assurance testing and product development laboratories and extraction and formulation processing. The facility is presently undergoing the interior completion to qualify it as GMP Euro compliant and is anticipated to be one of the highest performing and top product quality extraction and refining facilities in Canada. HTC has also completed the construction of its 27,000-square-foot hemp biomass processing and storage facility. The company reported the purchase of extraction and formulation equipment anticipated to begin arriving in December 2019. The equipment is slated to be used for hemp biomass processing, extraction, formulation and refining at its facility located at Port Lajord. Additionally, the company reported that it is in late stage negotiations for the acquisition of a United States based, fully licensed, hemp processing, extraction, formulation and distribution operation. HTC is also in late stage negotiations for Identity Preserved Grown (“IPGrow(TM)”) hemp biomass tolling contracts with producers and providers in the United States for the 2020 hemp production growing year, including a 60,000-acre recognized Canadian farm leader who is a significant IPGrow(TM) hemp biomass producer. The company intends to enter a tolling contract with this producer for the 2019, 2020 and 2021 crop years. This contract is anticipated to represent production from a single producer of approximately 4,300 acres from the 2019 production crop year and up to 25,000 acres for the 2020 and 2021 production crop years. In addition, HTC intends to leverage its relationship with its related entity, Purely Canada Foods(TM), to provide sales and distribution for its Ingredient CBD and cannabinoid market under the brand of Purely Canada Hemp(TM), Purely Canada CBD(TM), Purely Canada CBG(TM), and Purely Canada Cannabinoids(TM).

To view the full press release, visit http://ibn.fm/jTqIv

About HTC Extraction Systems

HTC Extraction Systems has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp-biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction and purification systems are engineered to large scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced. For more information, visit the company’s website at www.HTCExtraction.com.

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Predictive Oncology Inc.’s (NASDAQ: POAI) Valuable Database Offers Hope to Cancer Patients of Today and Tomorrow

• Predictive Oncology Inc. harnessing the power of artificial intelligence and its rich database of tumor data to help clinicians match cancer patients with most effective drug treatments
• Like Amazon’s customer dataset, POAI’s deep database of historical tumor information positions it for industry success
• Precision medicine is a data problem – demonstrates the huge value of data and those companies that generate it

When shopping on Amazon, it seems like the multinational technology company knows its customers intimately. Every product filtered into a search query response seems carefully curated to match each customer. This ability to leverage big data has pushed Amazon to the peak of success, and it now accounts for approximately 50 percent of all purchases made online (http://ibn.fm/0s6Qw).

Amazon’s success is a result of the company’s deep historical dataset of customer purchase profiles and its ability to leverage that with technologies such as AI. Across multiple industries from e-commerce, through finance to health care, there is now a recognition that data and the algorithms that help make sense of data are increasingly valuable and a key competitive differentiator.

From the health care field Predictive Oncology Inc. (NASDAQ: POAI) has been garnering industry attention as a hidden gem in the field of precision medicine for its innovative use of data and algorithms.

Precision Oncology is harnessing the power of artificial intelligence (think algorithms) to revolutionize treatment outcomes for cancer patients. What sets POAI apart from its competitors is the same factor that fueled Amazon’s rise: data. POAI (via its Helomics acquisition) has a huge proprietary database of tumor information, gathered from over 15+ years of clinical testing, which uniquely contains the drug responses of 150,000 individual patient tumors. Like Amazon’s database, which grows with each purchase, this unique tumor database grows daily as new tumors are tested.

While the use of data in cancer diagnostics is becoming more commonplace (think BRCA gene testing for breast cancer), for most patients the genomic data gathered from their tumor is not actionable, because researchers have a poor understanding of what mutations are important for choosing therapy. In the Amazon example, it would be like knowing people purchased dog food and cat litter but failing to predict they should buy cat food. POAI’s unique data on tumor drug response builds AI-driven predictive models that bring together the mutational and drug response profiles of the tumor to offer true actionable insights.

POAI is working with the pharmaceutical, diagnostic, and biotech industries to use its predictive models to both improve the development of new drugs (patients of tomorrow) as well as help clinicians individualize therapy (patients of today).

One disruptive aspect of POAI’s technology is that it helps the clinician to increase the chance of choosing more effective therapy, resulting in potential reduction of side-effects as well as cost savings. Traditionally oncologists prescribe what drugs they think have the best chance at beating a patient’s cancer, and the drug may or may not prove effective. Meanwhile, the patient’s undergoes chemotherapy with often debilitating side effects. If the drug proves to be a poor fit for the patient’s cancer, the chemotherapy experience will have been in vain, and the patient must continue acting as a guinea pig in experimenting with the next likely drug candidate. This is the standard cancer treatment of today. However, by utilizing POAI’s innovative tumor-profiling platform, which literally performs chemotherapy on the patient’s tumor outside the body to determine which drug is most effective, the patient can be spared many of the risks of being a “guinea-pig” as the oncologist attempts different drugs.

As Predictive leverages the data from its huge database of 150,000 of these “chemo outside the body” tests to build new predictive models, the ability to help the clinician choose the most effective drug for a patient cancer will improve. In addition, Predictive’s valuable predictive model will be a boon to the pharmaceutical industry in their race to develop new drugs to fight cancer.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

VPR Brands LP (VPRB) Among Industry Players Awaiting Final USDA Hemp Rules

• VPRB among key players anticipating United States Department of Agriculture (USDA) final draft rules on industrial hemp
• USDA’s Deputy Secretary Stephen Censky noted the regulations’ release to be expected within weeks, ahead of 2020 planting season
• Interim rules drafted include input from myriad voices; intend to relieve burden on producers, stakeholders

VPR Brands LP (OTCQB: VPRB), a multi-vertical tiered technology holding company in the cannabis space including vaping, joins other hemp industry players in their anticipation of the United States Department of Agriculture’s (USDA) release of an interim final rule for its Hemp Program. This announcement is timed in advance of the 2020 planting season and should guide producers with a framework for their activities (http://ibn.fm/fi3RB).

“We would expect to be issuing the interim final rule here within the next couple of weeks,” USDA deputy secretary Stephen Censky said in his testimony to the Senate Agricultural Committee. “We have been working in the interagency clearance process for over 90 days, working with some of our federal colleagues through the [White House Office of Management and Budget] process to get input there.” Censky noted that the committee is nearing the end of that process.

Censky referenced the work done by the USDA’s Agricultural Marketing Service (AMS) to prepare legislation for the upcoming growing session, much of which was influenced by key stakeholders. The committee sought to solicit stakeholder feedback through several avenues, including an open webinar listening session during March of 2019 where many voices were heard. The overall goal of the initiative, he noted, has been to eliminate conflict between producers and existing programs and to ensure that the “burden on producers and other stakeholders is minimized.”

Areas to be covered by the regulations include land use, certification, product testing and disposal of hemp containing excess THC (http://ibn.fm/tQ14Z). Censky said, “Many voices were represented during this listening session, and the insights offered during this and other stakeholder input were used by AMS to draft an interim rule.”

For hemp industry players like VPRB, this near-term release of an interim final rule on federal hemp regulations offers relief. A Hemp Program release prior to the 2020 planting season would provide direction to industry producers who seek a solid framework to guide their future activities.

Prior to 2018, industrial hemp production was prohibited because cannabis itself was a Schedule 1 controlled substance. While passage of the 2018 Farm Bill legalized the cultivation of industrial hemp, regulation is still catching up with the industry’s growth. For hemp industry stakeholders like VPRB that seek to execute strong strategy based on a solid foundation of growing practices, these regulations offer desired guidance.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Obtains C$5 Million Convertible Loan Financing

Lithium-focused exploration company Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning announced the company’s entrance into a C$5,000,000 loan and guarantee agreement with LANXESS Corporation (the “lender”). The loan has been fully advanced to the company as US$3,750,000, based on an agreed exchange rate, and will be utilized in the ongoing development of a demonstration plant in southern Arkansas. The plant is intended to demonstrate Standard Lithium’s proprietary process for the extraction of lithium from brine solutions. The principal amount of the loan will be convertible at a rate of one common share and one-half of a warrant to purchase an additional common share for each C$0.80 of principal converted. The warrants are exercisable at a price of C$1.20 per common share for a term of three years. Full conversion of the loan principal would result in the lender receiving 6,251,250 common shares and 3,125,625 warrants. All securities issued upon conversion of the loan are subject to a statutory hold period of four months and one day from the date the loan was advanced. The outstanding principal amount of the loan will bear interest at an annual rate of 3%, subject to adjustments. In the event that Standard Lithium has a positive consolidated operating cash flow, as shown on its financial statements, the company will pay a fee to the lender of 4.5% per annum on the average daily outstanding principal amount of the loan from the issuance date to the date that the consolidated operating cash flow is positive. Following the date on which the consolidated operating cash flow of Standard Lithium is positive, the annual interest rate will increase to 7.5%. Pre-payments are allowed with prior written approval of the lender and are subject to a prepayment fee of 3% on the portion of the loan being prepaid. The loan is due in full on the fifth anniversary, subject to the provision that at any time after second anniversary the lender may elect an earlier maturity date on 60 days’ notice. The loan is secured by a charge on the shares of Standard Lithium’s direct and indirect subsidiaries, Arkansas Lithium Corp., Vernal Minerals Corp., and 2661881 Ontario Limited, as well as by a security interest in the tangible and intangible property of Standard Lithium and the subsidiaries.

To view the full press release, visit http://ibn.fm/dTjCw

About Standard Lithium Ltd.

Standard Lithium is a specialty chemical company focused on unlocking the value of existing large-scale U.S.-based lithium-brine resources. The company believes new lithium production can be brought on stream rapidly by minimizing project risks at selection stage (resource, political, geographic, regulatory and permitting), and by leveraging advances in lithium extraction technologies and processes. The company’s flagship project is located in southern Arkansas, where it is engaged in the testing and proving of the commercial viability of lithium extraction from over 150,000 acres of permitted brine operations. The company is currently installing a first-of-its-kind Demonstration Plant that will use the company’s proprietary technology to selectively extract lithium from LANXESS’ tailbrine. This Demonstration Plant will be used to prove commercial feasibility. The environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. The company is also pursuing the resource development of over 30,000 acres of separate brine leases located in southwestern Arkansas and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. For more information, visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to STLHF are available in the company’s newsroom at http://ibn.fm/STLHF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ChineseInvestors.com Inc. (CIIX) Subsidiary to Attend Industrial Cannabis Conferences in China

ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal and a leading industrial hemp retailer for the Chinese-speaking community, today announced that its subsidiary CBD Biotech, Inc. will attend the “2019 China Industrial Cannabis Investment Seminar” in Shanghai, China on October 31, 2019 and the “2019 China Industrial Cannabis CBD Industry International Conference” in Haerbing, China on November 23-24, 2019. CBD Biotech executives will be available at each of the events to provide information and education on its industrial hemp-infused skincare and cosmetic products, its hemp wine, as well as to discuss strategic plans for future development. CBD Biotech will also feature two new industrial hemp products, which are slated to launch soon, at the conferences.

To view the full press release, visit http://ibn.fm/d22Bf

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Departure of Chief Advocacy Officer

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Tuesday announced that it has parted ways with its Chief Advocacy Officer John Fowler. In the update, Supreme Cannabis thanked Fowler for his years of dedication and strong contribution to the company, as well as his passion for the cannabis plant. Fowler is a strong believer in the cultivation of high-end cannabis and was one of the original founders of Supreme Cannabis’ flagship brand, 7ACRES. “We all wish John the best in his next endeavor and thank him for his commitment to the company for the last four years. John recognized the value of high-quality cannabis at scale and was instrumental in the creation of 7ACRES,” Supreme Cannabis CEO Navdeep Dhaliwal said in the news release. “The company and its strong management team is excited to continue its path to growth as a leader in differentiated cannabis brands and premium cultivation at scale, while exporting our team’s vast knowledge and experience globally.”

To view the full press release, visit http://ibn.fm/TIIjx

About Supreme Cannabis Company

The Supreme Cannabis Company, Inc., is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the company has emerged as one of the world’s fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products. Supreme Cannabis’ portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Blissco, a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada. Supreme trades as FIRE on the Toronto Stock Exchange (TSX: FIRE), SPRWF on the OTC Exchange in the United States (OTCQX: SPRWF) and 53S1 on the Frankfurt Stock Exchange (FRA: 53S1). Follow the company on Instagram, Twitter, Facebook and YouTube. For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – GP Solutions, Inc. (GWPD) Launches Proprietary, Cost-Effective Growth Medium

GP Solutions (OTC: GWPD), the developer of proprietary, automated micro-farms called GrowPods, on Tuesday announced the launch of Prolific, a unique, proprietary soilless growth medium and nutrient line that is free of human and sewage waste. Formulated by GP Solutions’ in-house scientists, Prolific consists of organic ingredients, requires little fertilization to sustain plant strength, and is reusable, making it cost-effective and sustainable. Prolific will be available in better garden centers, farm equipment and materials stores, and on the GP Solutions’ website. “Our objective was to develop a growth medium that will help give plants the proper nutrients they need to reach their genetic potential. Through our research and development, we created an ideal composition of natural ingredients that provide rich, contaminant-free growing conditions,” GP Solutions president George Natzic stated in the news release. “GP Solutions’ Prolific is an excellent choice for growing organic vegetables and herbs in enclosed growing environments, such as indoor farms of any size, greenhouses, potted plants, and shipping container farms. Prolific provides an all-in-one solution that is suitable for beginners, advanced gardeners, and professional farmers.”

To view the full press release, visit http://ibn.fm/zQFwH

About GP Solutions, Inc.

GP Solutions, Inc. is the developer of highly innovative automated micro-farms trade named “GrowPods.” GrowPods are a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. Offering fully insulated, food-grade shipping container that has been specifically modified to provide the optimum controlled environment for growing a wide range of horticultural and agricultural products in all environments and climates. With the company’s combination of hydroponic and certified organic soil systems, clients can produce a significantly higher yield that grows faster, healthier and more consistent. For more information, visit the company’s website at www.GrowPodSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to GWPD are available in the company’s newsroom at http://ibn.fm/GWPD

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php